LabGenomics is explaining NEB's genomic analysis reagents at the KSMCB Epigenomics Division Symposium. Provided by LabGenomics.

LabGenomics is explaining NEB's genomic analysis reagents at the KSMCB Epigenomics Division Symposium. Provided by LabGenomics.

View original image

Genome molecular diagnostics specialist LabGenomics announced on the 16th that it participated in the ‘2024 Korean Society for Molecular and Cellular Biology (KSMCB) Epigenomics Division Symposium’ and showcased its latest technologies along with genome analysis products from New England Biolabs (NEB).


The event was held for three days starting from the 11th at Daemyung Resort Sono Felice Tower Center in Hongcheon, Gangwon Province. Hosted by the Epigenomics Division under KSMCB, domestic researchers gathered in one place to share the latest research trends.


LabGenomics attended the symposium to seek new collaboration opportunities and introduce its own and NEB’s products to researchers. The company laid the groundwork for expanding future research collaborations through strategies such as ▲forming networks with epigenomics and epigenetics researchers ▲creating long-term cooperation opportunities with academia and research institutions ▲promoting next-generation sequencing (NGS) services and NEB products to key customers, the researchers ▲and establishing a foundation for increased sales to related researchers.


A representative from LabGenomics’ Future Business Team stated, “Through attending this symposium, we formed networks with researchers from major research institutions located in Seoul, Gyeonggi, and other provinces, including Professor Lee Jeongshin, head of the Department of Molecular Life Sciences at Kangwon National University, Professor Lee Cheolhwan, secretary of Seoul National University College of Medicine, and Professor Park Seongho, secretary of Ulsan National Institute of Science and Technology (UNIST). We look forward to developing these into long-term collaborative relationships.”



Meanwhile, LabGenomics signed a distribution rights contract for genome analysis reagents with the US-based NEB in December last year.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing